Journal: OncoTargets and therapy
Article Title: Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation
doi: 10.2147/OTT.S209907
Figure Lengend Snippet: The effect of NCTD on BCSLCs in vitro. ( A ) The protein expression of Cdc6-C in BCSLCs after NCTD treatment for 48 hr (0 μM, 50 μM, 100 μM and 200 μM) was detected by Western blotting. ( B ) The relative OD for Cdc6-C was determined from the Western blot band. ( C ) The expression of ATR-C, pChk1, pCdc25C in BCSLCs and UMUC3 cells after treatment with or without NCTD (50 μM) was detected by Western blotting. ( D – F) The relative OD data for ATR-C, pChk1, pCdc25C was determined from the Western blot band. ( G ) Relative cell viability of different groups is shown. (* P <0.05). Abbreviations: BCSLCs, bladder cancer stem-like cells; Cdc6-C, chromatin-binding Cdc6; NCTD, norcantharidin; ATR-C, Chromatin-binding ATR; pChk1, phosphorylated check point kinase 1; pCdc25C, phosphorylated Cdc25C.
Article Snippet: Cells from human bladder cancer cells line UMUC3 (obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA)) were cultured through the standard procedure in RPMI-1640 (Gibco, Grand Island, NY, USA) with 10% fetal bovine serum (Gibco), 1% penicillin and 1% streptomycin (Gibco) under standard conditions (5% CO2 and 95% atmosphere, 37 °C).
Techniques: In Vitro, Expressing, Western Blot, Binding Assay